Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Interest Expenses (2018 - 2025)

Bioadaptives' Interest Expenses history spans 7 years, with the latest figure at $11017.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 125.04% to $11017.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $44466.0, a 895.31% increase, with the full-year FY2025 number at $44466.0, up 16.17% from a year prior.
  • Interest Expenses hit $11017.0 in Q4 2025 for Bioadaptives, down from $14153.0 in the prior quarter.
  • Over the last five years, Interest Expenses for BDPT hit a ceiling of $251218.0 in Q4 2022 and a floor of -$88132.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $27303.5 across 5 years, with a median of $14993.0 in 2021.
  • Biggest five-year swings in Interest Expenses: tumbled 270.76% in 2021 and later surged 385.05% in 2022.
  • Tracing BDPT's Interest Expenses over 5 years: stood at -$88132.0 in 2021, then surged by 385.05% to $251218.0 in 2022, then tumbled by 132.19% to -$80879.0 in 2023, then surged by 45.59% to -$44003.0 in 2024, then skyrocketed by 125.04% to $11017.0 in 2025.
  • Business Quant data shows Interest Expenses for BDPT at $11017.0 in Q4 2025, $14153.0 in Q3 2025, and $9649.0 in Q2 2025.